PL3224376T3 - Zanieczyszczenia DNA w kompozycji zawierającej wiriony parwowirusowe - Google Patents
Zanieczyszczenia DNA w kompozycji zawierającej wiriony parwowirusoweInfo
- Publication number
- PL3224376T3 PL3224376T3 PL15801422T PL15801422T PL3224376T3 PL 3224376 T3 PL3224376 T3 PL 3224376T3 PL 15801422 T PL15801422 T PL 15801422T PL 15801422 T PL15801422 T PL 15801422T PL 3224376 T3 PL3224376 T3 PL 3224376T3
- Authority
- PL
- Poland
- Prior art keywords
- composition
- dna impurities
- parvoviral virion
- parvoviral
- virion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14195464 | 2014-11-28 | ||
| PCT/EP2015/077882 WO2016083560A1 (en) | 2014-11-28 | 2015-11-27 | Dna impurities in a composition comprising a parvoviral virion |
| EP15801422.5A EP3224376B2 (en) | 2014-11-28 | 2015-11-27 | Dna impurities in a composition comprising a parvoviral virion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL3224376T3 true PL3224376T3 (pl) | 2020-03-31 |
| PL3224376T5 PL3224376T5 (pl) | 2023-08-21 |
Family
ID=52000715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15801422.5T PL3224376T5 (pl) | 2014-11-28 | 2015-11-27 | Zanieczyszczenia DNA w kompozycji zawierającej wiriony parwowirusowe |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11021762B2 (pl) |
| EP (3) | EP3224376B2 (pl) |
| JP (1) | JP6741345B2 (pl) |
| KR (1) | KR102528156B1 (pl) |
| CN (1) | CN107208142B (pl) |
| AU (1) | AU2015352469B2 (pl) |
| BR (1) | BR112017011217A2 (pl) |
| CA (1) | CA2968622A1 (pl) |
| CY (1) | CY1122223T1 (pl) |
| DK (2) | DK3591070T3 (pl) |
| EA (1) | EA035747B1 (pl) |
| ES (1) | ES2751919T5 (pl) |
| FI (1) | FI3224376T4 (pl) |
| HK (1) | HK1244849B (pl) |
| HU (1) | HUE046643T2 (pl) |
| PL (1) | PL3224376T5 (pl) |
| PT (1) | PT3224376T (pl) |
| SI (1) | SI3224376T2 (pl) |
| WO (1) | WO2016083560A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2020109343A (ru) | 2014-11-05 | 2020-03-17 | Вояджер Терапьютикс, Инк. | Полинуклеотиды aadc для лечения болезни паркинсона |
| DK3218386T3 (da) | 2014-11-14 | 2021-06-07 | Voyager Therapeutics Inc | Modulatorisk polynukleotid |
| MX2017006216A (es) | 2014-11-14 | 2018-08-29 | Voyager Therapeutics Inc | Composiciones y métodos para tratar la esclerosis lateral amiotrófica (ela). |
| PL3224376T5 (pl) | 2014-11-28 | 2023-08-21 | Uniqure Ip B.V. | Zanieczyszczenia DNA w kompozycji zawierającej wiriony parwowirusowe |
| EP3230441A4 (en) | 2014-12-12 | 2018-10-03 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scaav |
| GB2536650A (en) | 2015-03-24 | 2016-09-28 | Augmedics Ltd | Method and system for combining video-based and optic-based augmented reality in a near eye display |
| IL302748A (en) | 2016-05-18 | 2023-07-01 | Voyager Therapeutics Inc | modulatory polynucleotides |
| CN110913866A (zh) | 2017-05-05 | 2020-03-24 | 沃雅戈治疗公司 | 治疗肌萎缩性侧索硬化(als)的组合物和方法 |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| US11980507B2 (en) | 2018-05-02 | 2024-05-14 | Augmedics Ltd. | Registration of a fiducial marker for an augmented reality system |
| US11766296B2 (en) | 2018-11-26 | 2023-09-26 | Augmedics Ltd. | Tracking system for image-guided surgery |
| US11980506B2 (en) | 2019-07-29 | 2024-05-14 | Augmedics Ltd. | Fiducial marker |
| US11382712B2 (en) | 2019-12-22 | 2022-07-12 | Augmedics Ltd. | Mirroring in image guided surgery |
| WO2022188797A1 (en) | 2021-03-09 | 2022-09-15 | Huigene Therapeutics Co., Ltd. | Engineered crispr/cas13 system and uses thereof |
| US11896445B2 (en) | 2021-07-07 | 2024-02-13 | Augmedics Ltd. | Iliac pin and adapter |
| WO2023283962A1 (en) | 2021-07-16 | 2023-01-19 | Huigene Therapeutics Co., Ltd. | Modified aav capsid for gene therapy and methods thereof |
| CN117660534B (zh) * | 2023-12-13 | 2024-05-07 | 广州派真生物技术有限公司 | 一种降低重组腺相关病毒中宿主细胞dna残留的辅助质粒及应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| EP1231282A3 (en) * | 1990-12-06 | 2005-05-18 | Affymetrix, Inc. | Methods and compositions for identification of polymers |
| US6491907B1 (en) | 1998-11-10 | 2002-12-10 | The University Of North Carolina At Chapel Hill | Recombinant parvovirus vectors and method of making |
| CA2385823A1 (en) | 1999-10-01 | 2001-04-12 | Haifeng Chen | Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| ES2862206T3 (es) | 2003-06-19 | 2021-10-07 | Genzyme Corp | Viriones de AAV con inmunorreactividad disminuida y sus usos |
| CN101018858A (zh) * | 2004-06-01 | 2007-08-15 | 建新公司 | 防止aav载体聚集的组合物和方法 |
| SI1945779T1 (sl) | 2005-10-20 | 2013-07-31 | Uniqure Ip B.V. | Izboljĺ ani aav vektorji proizvedeni v celicah insekta |
| CN103849629B (zh) | 2006-06-21 | 2017-06-09 | 尤尼克尔Ip股份有限公司 | 具有经修饰的用于在昆虫细胞中产生aav的aav‑rep78翻译起始密码子的载体 |
| WO2008105931A2 (en) * | 2006-09-15 | 2008-09-04 | Medimmune Vaccines, Inc. | Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
| AU2008279883B2 (en) | 2007-07-26 | 2013-12-05 | Uniqure Ip B.V. | Baculoviral vectors comprising repeated coding sequences with differential codon biases |
| CN102007209B (zh) | 2008-02-19 | 2013-11-13 | 阿姆斯特丹分子治疗(Amt)股份有限公司 | 细小病毒rep和cap蛋白在昆虫细胞中的表达优化 |
| EP2529020B1 (en) | 2010-01-28 | 2018-04-25 | The Children's Hospital of Philadelphia | A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
| WO2011112089A2 (en) | 2010-03-11 | 2011-09-15 | Amsterdam Molecular Therapeutics (Amt) Ip B.V. | Mutated rep encoding sequences for use in aav production |
| KR101334072B1 (ko) * | 2010-11-25 | 2013-11-29 | 한국표준과학연구원 | 핵산 정량 방법 및 키트 |
| CN103703146A (zh) | 2011-07-19 | 2014-04-02 | 株式会社日立高新技术 | 核酸分析方法和核酸分析装置 |
| FR2986239A1 (fr) | 2012-01-31 | 2013-08-02 | Univ Strasbourg | Biomarqueur pour les maladies inflammatoires pulmonaires chroniques |
| WO2014007120A1 (ja) * | 2012-07-06 | 2014-01-09 | タカラバイオ株式会社 | アデノ随伴ウイルスベクターの産生細胞 |
| CN104685064A (zh) * | 2012-07-24 | 2015-06-03 | 纳特拉公司 | 高度复合pcr方法和组合物 |
| EP2970943A4 (en) * | 2013-03-15 | 2017-04-19 | The Children's Hospital of Philadelphia | Vectors comprising stuffer/filler polynucleotide sequences and methods of use |
| PL3224376T5 (pl) | 2014-11-28 | 2023-08-21 | Uniqure Ip B.V. | Zanieczyszczenia DNA w kompozycji zawierającej wiriony parwowirusowe |
-
2015
- 2015-11-27 PL PL15801422.5T patent/PL3224376T5/pl unknown
- 2015-11-27 KR KR1020177017590A patent/KR102528156B1/ko active IP Right Grant
- 2015-11-27 FI FIEP15801422.5T patent/FI3224376T4/fi active
- 2015-11-27 US US15/531,095 patent/US11021762B2/en active Active
- 2015-11-27 EP EP15801422.5A patent/EP3224376B2/en active Active
- 2015-11-27 DK DK19189091.2T patent/DK3591070T3/da active
- 2015-11-27 DK DK15801422.5T patent/DK3224376T4/da active
- 2015-11-27 AU AU2015352469A patent/AU2015352469B2/en active Active
- 2015-11-27 HU HUE15801422A patent/HUE046643T2/hu unknown
- 2015-11-27 WO PCT/EP2015/077882 patent/WO2016083560A1/en active Application Filing
- 2015-11-27 BR BR112017011217-5A patent/BR112017011217A2/pt not_active Application Discontinuation
- 2015-11-27 PT PT158014225T patent/PT3224376T/pt unknown
- 2015-11-27 EP EP22213794.5A patent/EP4219742A1/en active Pending
- 2015-11-27 EP EP19189091.2A patent/EP3591070B1/en active Active
- 2015-11-27 JP JP2017528531A patent/JP6741345B2/ja active Active
- 2015-11-27 CN CN201580073778.8A patent/CN107208142B/zh active Active
- 2015-11-27 ES ES15801422T patent/ES2751919T5/es active Active
- 2015-11-27 EA EA201791184A patent/EA035747B1/ru not_active IP Right Cessation
- 2015-11-27 SI SI201530908T patent/SI3224376T2/sl unknown
- 2015-11-27 CA CA2968622A patent/CA2968622A1/en active Pending
-
2018
- 2018-03-26 HK HK18104138.5A patent/HK1244849B/zh unknown
-
2019
- 2019-11-01 CY CY20191101141T patent/CY1122223T1/el unknown
-
2021
- 2021-05-06 US US17/313,777 patent/US20210332447A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1244849B (zh) | 包含細小病毒病毒體的組合物中的dna雜質 | |
| IL247581A0 (en) | Genome editing without nucleases | |
| IL246951B (en) | A composition containing multiple genomes with crispr capability | |
| PL3102722T3 (pl) | Frakcjonowanie genomu | |
| GB201418892D0 (en) | DNA editing | |
| IL252591B (en) | Genomic architecture mapping | |
| SG11201704517SA (en) | Ink composition | |
| GB2534113B (en) | Ink composition | |
| GB201408467D0 (en) | Inks | |
| GB201509208D0 (en) | Improvements relating to printing | |
| GB201418353D0 (en) | Improvements in or relating to organic material | |
| GB2529132B (en) | Improvements in or relating to stairlifts | |
| GB2526621B (en) | Improvements in or relating to stairlifts | |
| GB201412505D0 (en) | Improvements relating to marking | |
| GB201400699D0 (en) | Improvements in or relating to servewear | |
| GB201403570D0 (en) | Ink composition | |
| GB201418307D0 (en) | Improvements in or relating to stairlifts | |
| SI2898888T1 (sl) | Sestavek, ki obsega iota-karagenan, proti virusnemu konjunktivitisu | |
| GB201514034D0 (en) | Improvements in or relating to DNA recombination | |
| GB201514005D0 (en) | Improvements in or relating to DNA recombination | |
| GB201508136D0 (en) | Improvements in or relating to dna recombination | |
| GB201400751D0 (en) | Ink composition | |
| GB201410947D0 (en) | Improvements to print compositions and processes including the same | |
| GB201407981D0 (en) | Ink compositions | |
| IL230674A0 (en) | Account management for employees |